| Name | 2-(6-chloropyrimidin-4-yl)-5-methylpyrazol-3-amine |
|---|---|
| Synonyms |
1-(6-Chloro-4-pyrimidinyl)-3-methyl-1H-pyrazol-5-amine
1-(6-chloropyrimidin-4-yl)-3-methyl-1H-pyrazol-5-amine 1H-Pyrazol-5-amine, 1-(6-chloro-4-pyrimidinyl)-3-methyl- |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 418.0±45.0 °C at 760 mmHg |
| Molecular Formula | C8H8ClN5 |
| Molecular Weight | 209.636 |
| Flash Point | 206.6±28.7 °C |
| Exact Mass | 209.046829 |
| PSA | 69.62000 |
| LogP | 1.22 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.731 |
| HS Code | 2933990090 |
|---|
|
~%
1018473-22-7 |
| Literature: IRM LLC; NOVARTIS AG Patent: WO2008/42639 A1, 2008 ; Location in patent: Page/Page column 81 ; WO 2008/042639 A1 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |